Assistant Professor Timothy Cernak Wins Competitive Research Grant

Media Contact: Lindsay Groth, Director of Marketing and Communications, [email protected]

[Ann Arbor, Michigan] — Timothy Cernak, Assistant Professor of Medicinal Chemistry and Chemistry, and his research team have been awarded a grant through the Meet the Moment Research Initiative, to advance efforts to develop effective treatments for fungal infections in endangered species – specifically frogs and bats. Collaborators on the grant include Tim James and Kelly Speer of the University of Michigan, and Brian Gratwicke of the Smithsonian Zoo.

Funded through the College of Literature, Sciences, and the Arts, or LSA, the Meet the Moment Research Initiative focuses on faculty research and scholarship across liberal arts that address pressing issues in society.

Cernak’s research looks at an infectious fungus found in many frog species called chytrid, and the fungus that causes white nose syndrome in bats. These fungal infections have led to drastic reductions in frog and bat populations around the globe. The goal for his team is to eradicate the pending extinction of bats and frogs.

The team’s research is meant to help not only wildlife but humankind. The Centers for Disease Control and Prevention refers to this approach as One Health – the idea that the health of people is closely connected to the health of animals and our shared environment. You can read in-depth about Cernak’s work connecting medicinal chemistry to conservation in a recently published article in the Journal of Medicinal Chemistry.

For a full list of this year’s Meet the Moment Research Initiative awardees, read the release from LSA here.

________________

About the College

The University of Michigan College of Pharmacy has been leading at pharmacy’s edge for 150 years. The first and oldest pharmacy school at a state university, the College — currently ranked #2 in the nation — has and continues to shape education in the field. Its faculty are internationally recognized and are innovators in drug discovery, development and delivery, precision pharmacotherapy, outcomes research, and clinical practice. More than 5,000 alumni are enhancing patient care and outcomes from the bench to the bedside, in boardrooms and communities, government agencies, and within healthcare companies.